Differential expression of myc family genes during murine development

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Nature

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/319780A0PMID 2419762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human N-myc is closely related in organization and nucleotide sequence to c-myc

  1986cited by this paper
• L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer

  1985cited by this paper
• Establishment and identification of small cell lung cancer cell lines having classic and variant features.

  1985cited by this paper
• Amplification and altered expression of the c-myc oncogene in A-MuLV-transformed fibroblasts

  1985cited by this paper
• Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture

  1985cited by this paper
• N-myc can cooperate with ras to transform normal cells in culture.

  1985cited by this paper
• Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.

  1985cited by this paper
• Developmentally controlled and tissue-specific expression of unrearranged VH gene segments.

  1985cited by this paper
• Expression of the amplified domain in human neuroblastoma cells

  1984cited by this paper
• The molecular genetics of cellular oncogenes.

  1984cited by this paper
• Nucleotide sequence comparison of normal and translocated murine c-myc genes

  1984cited by this paper
• Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma.

  1984cited by this paper
• The Endocrine lung in health & disease

  1984cited by this paper
• Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc

  1984cited by this paper
• Expression and amplification of the N-myc gene in primary retinoblastoma

  1984cited by this paper
• Activated expression of the N-myc gene in human neuroblastomas and related tumors.

  1984cited by this paper
• Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29

  1983cited by this paper
• Transposition and amplification of oncogene-related sequences in human neuroblastomas.

  1983cited by this paper
• Differentiation of cloned populations of immature B cells after transformation with Abelson murine leukemia virus.

  1983cited by this paper
• Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

  1983cited by this paper
• Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes.

  1981cited by this paper

• MYC in cancer: from undruggable target to clinical trials

  2025cites this paper
• Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumors.

  2025cites this paper
• Recent advances in anti-tumor therapeutic approaches for the universally active transcriptional factor c-MYC

  2024cites this paper
• Expansion of a neural crest gene signature following ectopic MYCN expression in sympathoadrenal lineage cells in vivo

  2024cites this paper
• Preclinical Pharmacokinetics in Tumors and Normal Tissues of the Antigene PNA Oligonucleotide MYCN-Inhibitor BGA002

  2024cites this paper
• Discovering genes and microRNAs involved in human lung development unveils IGFBP3/miR-34a dynamics and their relevance for alveolar differentiation

  2024cites this paper
• A phenome-wide association study of polygenic scores for selected childhood cancer: Results from the UK Biobank

  2024cites this paper
• Immune evasion: An imperative and consequence of MYC deregulation

  2024cites this paper
• Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma

  2023cites this paper
• Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration

  2023cites this paper
• Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development

  2023cites this paper
• The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics

  2023influential citation
• The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma

  2022cites this paper
• SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma

  2022cites this paper
• Auxiliary pluripotency-associated genes and their contributions in the generation of induced pluripotent stem cells

  2022cites this paper
• Thyroid hormone receptor α controls larval intestinal epithelial cell death by regulating the CDK1 pathway

  2022cites this paper
• Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN

  2022cites this paper
• Interplay: The Essential Role between INSM1 and N-Myc in Aggressive Neuroblastoma

  2022cites this paper
• Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs

  2022cites this paper
• MYCN and Metabolic Reprogramming in Neuroblastoma

  2022cites this paper
• Characterization and function of mandarin fish c-Myc during viral infection process.

  2021cites this paper
• Genome-wide expression of the residual lung reacting to experimental Pneumonectomy

  2021cites this paper
• NBAT1/CASC15-003/USP36 control MYCN expression and its downstream pathway genes in neuroblastoma

  2021cites this paper
• Perspective on Similarities and Possible Overlaps of Congenital Disease Formation—Exemplified on a Case of Congenital Diaphragmatic Hernia and Neuroblastoma in a Neonate

  2021cites this paper
• A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma

  2021cites this paper
• MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma

  2021cites this paper
• Function of Oncogene Mycn in Adult Neurogenesis and Oligodendrogenesis

  2021cites this paper
• Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs

  2021influential citation
• MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma

  2021cites this paper
• Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma

  2021cites this paper
• Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead

  2021cites this paper
• MYCN Function in Neuroblastoma Development

  2021cites this paper
• C-Myc signaling pathway in treatment and prevention of brain tumors.

  2020cites this paper
• A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma

  2020cites this paper
• Platform Effects on Regeneration by Pulmonary Basal Cells as Evaluated by Single-Cell RNA Sequencing

  2020cites this paper
• MYC, MYCL, and MYCN as therapeutic targets in lung cancer

  2020cites this paper
• Regulation of Neuroblastoma Malignant Properties by Pannexin 1 Channels: Role of Post-Translational Modifications and Mutations

  2020cites this paper
• MYCN Silencing by RNAi Induces Neurogenesis and Suppresses Proliferation in Models of Neuroblastoma with Resistance to Retinoic Acid

  2020cites this paper
• Myc as a Regulator of Ribosome Biogenesis and Cell Competition: A Link to Cancer

  2020cites this paper
• New targeted therapies for malignant neural tumors From systematic discovery to zebrafish models

  2020cites this paper
• Disruption of neural crest enhancer landscapes as an etiological mechanism for human neurocristopathies

  2019cites this paper
• Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCN

  2019cites this paper
• State of the art in immunotherapy of neuroblastoma.

  2019cites this paper
• Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma

  2019cites this paper
• Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma

  2019cites this paper
• Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer

  2019cites this paper
• A novel MYCN-specific antigene oligonucleotide deregulates mitochondria and inhibits tumor growth in MYCN-amplified Neuroblastoma.

  2019cites this paper
• Identification and characterization of small molecules targeting MYC function

  2019influential citation
• Myc is dispensable for cardiomyocyte development but rescues Mycn-deficient hearts through functional replacement and cell competition

  2019cites this paper
• Genetic manipulation of ureteric bud tip progenitors in the mammalian kidney through an Adamts18 enhancer driven tet-on inducible system.

  2019cites this paper
• Neuroblastoma—A Neural Crest Derived Embryonal Malignancy

  2019cites this paper
• The Expanding World of N-MYC-Driven Tumors.

  2018cites this paper
• The balance of two opposing factors Mad and Myc regulates cell fate during tissue remodeling

  2018cites this paper
• DEVELOPMENT OF A HUMAN EMBRYONIC STEM CELL BASED PLATFORM FOR NEUROBLASTOMA TUMOUR MODELLING

  2018cites this paper
• Polymorphisms in MYCN gene and neuroblastoma risk in Chinese children: a 3-center case–control study

  2018cites this paper
• C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells

  2018cites this paper
• Cell death-based treatment of neuroblastoma

  2018cites this paper
• MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling

  2018cites this paper
• Neuroblastoma

  2018cites this paper
• Role of an N2-Src-COPII pathway in neuroblastoma differentiation

  2018cites this paper
• Mitochondria targeting and its consequences for cell death in neuroblastoma

  2018cites this paper
• Multiple Roles of MYC in Integrating Regulatory Networks of Pluripotent Stem Cells

  2017cites this paper
• Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation

  2017cites this paper
• Determination of Myc Genes Mutations in Patients with Leukemiafrom Turkey

  2017cites this paper
• Expression and modulation of potassium channels in neuroblastoma

  2017cites this paper
• Family matters: How MYC family oncogenes impact small cell lung cancer

  2017cites this paper
• Integrated expression analysis identifies transcription networks in mouse and human gastric neoplasia

  2017cites this paper
• Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression

  2017cites this paper
• The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance

  2017cites this paper
• Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling

  2017cites this paper
• Metabolism and neural differentiation in childhood neuroblastoma

  2017cites this paper
• MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma

  2017cites this paper
• Biology and evolution of poorly differentiated neuroendocrine tumors

  2017cites this paper
• The MYCN Protein in Health and Disease

  2017cites this paper
• MYCN, proliferative heterogeneity and treatment responsein neuroblastoma

  2017cites this paper
• Glutathione biosynthesis is upregulated at the initiation of MYCN‐driven neuroblastoma tumorigenesis

  2016cites this paper
• MYCN-targeting vaccines and immunotherapeutics

  2016cites this paper
• Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients.

  2016cites this paper
• L1-CAM knock-down radiosensitizes neuroblastoma IMR-32 cells by simultaneously decreasing MycN, but increasing PTEN protein expression.

  2016cites this paper
• Single nucleotide polymorphism rs11669203 in TGFBR3L is associated with the risk of neuroblastoma in a Chinese population

  2016cites this paper
• Alternative regulation of MYC in lung cancer

  2016cites this paper
• Cell Proliferation in Neuroblastoma

  2016cites this paper
• Social stress in adolescents induces depression and brain-region-specific modulation of the transcription factor MAX

  2016cites this paper
• Regulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous System

  2016cites this paper
• Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma

  2015cites this paper
• Karyotype restructuring in Rodentia: from evolution to cancer

  2015cites this paper
• ABC transporters and neuroblastoma.

  2015cites this paper
• Epigenetic role of N-Myc in Neuroblastoma

  2015cites this paper
• Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis

  2015cites this paper
• MYCN overexpression is associated with unbalanced copy number gain, altered nuclear location, and overexpression of chromosome arm 17q genes in neuroblastoma tumors and cell lines

  2015cites this paper
• Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma

  2015cites this paper
• Understanding the mechanism of MYC induced vulnerabilities

  2015influential citation
• c-Myc Signalling in the Genetic Mechanism of Polycystic Kidney Disease

  2015cites this paper
• Tumors of the neural crest: Common themes in development and cancer

  2015cites this paper
• SMARCAL1 Negatively Regulates C-Myc Transcription By Altering The Conformation Of The Promoter Region

  2015cites this paper
• Transcription factor activating protein 4 is synthetic lethal and a master regulator of MYCN amplified neuroblastoma

  2015cites this paper
• c-myc in whitefish (Coregonus lavaretus): structure, expression, and insights into possible posttranscriptional regulatory mechanism

  2015cites this paper
• An unexpected role for caspase-2 in neuroblastoma

  2014cites this paper
• Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors

  2014cites this paper
• Genetics of gastrointestinal atresias.

  2014cites this paper